BRAINLIFE.ORG





Current Neuro-Oncology




Volume 26 Number 19
10 September 2024




Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 19, 10 September








Hiong A, Lapidus AH, Gately L, Sinclair G, Ameratunga M.
Herpes zoster in patients with glioma treated with temozolomide.
J Clin Neurosci. 2024 Sep 1;129:110816. doi: 10.1016/j.jocn.2024.110816? PMID: 39222582. Observational study˰ ˍ




Simoneau J, Robertson P, Muraszko K, Maher CO, Garton H, Calvert R, Koschmann C, Upadhyaya SA, Mody R, Brown N, Kumar-Sinha C, Parmar H, Camelo-Piragua S, Franson AT.
Long-Term Tumor Stability After First-Line Treatment With Larotrectinib in an Infant With NTRK2 Fusion-Positive High-Grade Glioma.
J Natl Compr Canc Netw. 2024 Sep;22(7):e247045. doi: 10.6004/jnccn.2024.7045. PMID: 39236755. Case report. ˍ




Li F, Wang D, Wang N, Wu L, Yu B.
A nomogram with Ki-67 in the prediction of postoperative recurrence and death for glioma.
Sci Rep. 2024 Sep 2;14(1):20334. doi: 10.1038/s41598-024-71275-9. PMID: 39223159. Observational study. ˍ




**Löding S, Antti H, Sjöberg RL, Melin B, Björkblom B.
Blood based metabolic markers of glioma from pre-diagnosis to surgery.
Sci Rep. 2024 Sep 5;14(1):20680. doi: 10.1038/s41598-024-71375-6. PMID: 39237693. Observational study. ˍ




Lenga P, Kühlwein D, Grutza M, Issa M, Hinz F, Sahm F, Selt F, Milde T, Günther P, Unterberg AW, Krieg SM, Damaty AE.
Decoding pediatric spinal tumors: a single-center retrospective case series on etiology, presentation, therapeutic strategies, and outcomes.
Neurosurg Rev. 2024 Sep 6;47(1):557. doi: 10.1007/s10143-024-02770-w. PMID: 39240372. Observational study. ˍ




Soleimani Z, Saboori M, Abedi I, Irannejad M, Khanbabapour S.
Diffusion-weighted MR image analysis based on gamma distribution model for differentiating benign and malignant brain tumors.
Medicine (Baltimore). 2024 Sep 6;103(36):e39593. doi: 10.1097/MD.0000000000039593? PMID: 39252229. Observational study. ˍ




Zhang C, Wang J, Niu Z, Zhang K, Wang C, Wang S, Hou S, Yu D, Lin N.
Identification of a nomogram predicting overall survival based on ADAP2-related apoptosis genes in gliomas.
Int Immunopharmacol. 2024 Sep 6;142(Pt A):113084. doi: 10.1016/j.intimp.2024.113084. PMID: 39243555. Observational study˰ ˍ




Li R, Zhang Z, Zhang X, Song J, Wu Y, Wu L, Mao S, Jiang J, Zeng L.
Optimizing post-craniotomy recovery: insights from symptom network analysis in primary brain tumor patients.
Neurosurg Rev. 2024 Sep 7;47(1):565. doi: 10.1007/s10143-024-02804-3. PMID: 39242405. Observational study˰ ˍ




Basaran AE, Arlt F, Güresir E, Vychopen M, Wach J.
Sexual dysfunction after surgery for primary sporadic cranial meningiomas: prevalence and risk factors.
J Neurooncol. 2024 Sep 10. doi: 10.1007/s11060-024-04817-w. PMID: 39254812. Observational study. ˍ








*Greutter L, Miller-Michlits Y, Klotz S, Reimann R, Nenning KH, Platzek S, Krause E, Kiesel B, Widhalm G, Langs G, Baumann B, Woehrer A.
Frequent Alzheimer's disease neuropathological change in patients with glioblastoma.
Neurooncol Adv. 2024 Jul 9;6(1):vdae118. doi: 10.1093/noajnl/vdae118. PMID: 39220249. Observational study. ˍ




Youshani AS, Heal C, Lee JX, Younis M, Mohanraj R, Maye H, Bailey M, Coope D, D'Urso PI, Karabatsou K.
Glioma-related epilepsy following low-grade glioma surgery.
Neurooncol Adv. 2024 Jul 20;6(1):vdae127. doi: 10.1093/noajnl/vdae127. PMID: 39220245. Observational study. ˍ




Lee Y, Lee E, Roh TH, Kim SH.
Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma: A Nationwide Population-Based Study.
J Korean Med Sci. 2024 Jul 29;39(34):e244. doi: 10.3346/jkms.2024.39.e244. PMID: 39228184. Observational study. ˍ




*Fang CS, Wang W, Schroff C, Movahed-Ezazi M, Vasudevaraja V, Serrano J, Sulman EP, Golfinos JG, Orringer D, Galbraith K, Feng Y, Snuderl M.
Racial distribution of molecularly classified brain tumors.
Neurooncol Adv. 2024 Aug 2;6(1):vdae135. doi: 10.1093/noajnl/vdae135. PMID: 39220243. Observational study. ˍ




Nair PM, Ramalakshmi R, Devibala M, Saranya M, Sivaranjini S, Thangavelu R, Mahalingam M.
Integrative Oncology for High-Grade Glioma: A Case Report on the Combined Effects of Oncothermia and Complementary Therapies.
Cureus. 2024 Aug 9;16(8):e66492. doi: 10.7759/cureus.66492. PMID: 39246981. Case report. ˍ




Biedermann GB, Merrifield K, Lustgarten L.
Case report: Safety of Tumor Treating Fields therapy with an implantable cardiac pacemaker in a patient with glioblastoma.
Front Oncol. 2024 Aug 22;14:1441146. doi: 10.3389/fonc.2024.1441146. PMID: 39239269. Case report. ˍ




Zhou Y, Jia P, Fang Y, Zhu W, Gong Y, Fan T, Yin J.
Comprehensive understanding of the adverse effects associated with temozolomide: a disproportionate analysis based on the FAERS database.
Front Pharmacol. 2024 Aug 23;15:1437436. doi: 10.3389/fphar.2024.1437436. PMID: 39246656. Observational study. ˍ




Guo Y, Li Z, Parsels LA, Wang Z, Parsels JD, Dalvi A, The S, Hu N, Valvo VM, Doherty R, Peterson E, Wang X, Venkataraman S, Agnihotri S, Venneti S, Wahl DR, Green MD, Lawrence TS, Koschmann C, Morgan MA, Zhang Q.
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition.
bioRxiv [Preprint]. 2024 Aug 27:2024.08.26.609803. doi: 10.1101/2024.08.26.609803. PMID: 39253432. Laboratory investigation. ˍ




Li C, Zhou W, Wang P, Ji P, Wang Y, Guo S, Zhai Y, Xu M, Wang L, Feng F, Liu J.
Prognostic Factors for Patients With primary gliosarcoma: A Single-Center Retrospective Study.
World Neurosurg. 2024 Aug 30:S1878-8750(24)01497-9. doi: 10.1016/j.wneu.2024.08.128. PMID: 39216722. Observational study˰ ˍ




Ott K, Cepeda S, Hartmann D, Kramer F, Müller D.
Predicting Overall Survival of Glioblastoma Patients Using Deep Learning Classification Based on MRIs.
Stud Health Technol Inform. 2024 Aug 30;317:356-365. doi: 10.3233/SHTI240878. PMID: 39234740. Observational study. ˍ




Zhang H, Li J, Wan X, Liu Z.
A nomogram to predict cancer-specific mortality in adult patients with malignant meningioma: a competing risk analysis.
Discov Oncol. 2024 Aug 31;15(1):394. doi: 10.1007/s12672-024-01263-y. PMID: 39217259. Observational study. ˍ